Hypoxia-inducible factor-1a (HIF-1a) plays a central role in oxygen homeostasis. Previously, we reported that the orphan nuclear receptor Nur77 functions in stabilizing HIF-1a. Here, we demonstrate that 6-mercaptopurine (6-MP), an activator of the NR4A family members, enhances transcriptional activity of HIF-1. 6-MP enhanced the protein-level of HIF-1a as well as vascular endothelial growth factor (VEGF) in a dose-and timedependent manner. The induction of HIF-1a was abolished by the transfection of either a dominant-negative Nur77 mutant or si-Nur77, indicating a critical role of Nur77 in the 6-MP action. The HIF-1a protein level remained up to 60 min in the presence of 6-MP when de novo protein synthesis was blocked by cycloheximide, suggesting that 6-MP induces stabilization of the HIF-1a protein. The fact that 6-MP decreased the association of HIF-1a with von Hippel-Lindau protein and the acetylation of HIF-1a, may explain how 6-MP induced stability of HIF-1a. Further, 6-MP induced the transactivation function of HIF-1a by recruiting co-activator cyclic-AMP-responseelement-binding protein. Finally, 6-MP enhanced the expression of HIF-1a and VEGF, and the formation of capillary tubes in human umbilical vascular endothelial cells. Together, our results provide a new insight for 6-MP action in the stabilization of HIF-1a and imply a potential application of 6-MP in hypoxia-associated human vascular diseases.
Introduction
Cellular adaptation to changes in oxygen tension is an important process for a wide range of events including normal embryonic development and the pathophysiology of ischemic and neoplastic disorders. When cellular oxygen availability decreases, the transcription factor hypoxia-inducible factor-1 (HIF-1) plays a central role in cellular adaptation by stimulating the transcription of diverse genes that encode proteins that function to increase oxygen delivery, to allow metabolic adaptation, and to promote cell survival (Semenza, 2001) . Therefore, great attention has been paid to the factors that control the activity of HIF-1, with the aim of developing new therapies for many human diseases, such as cancer and cardiovascular disease.
HIF-1 consists of a and b subunits, both of which belong to the basic helix-loop-helix/PER-ARNT-SIM (bHLH/PAS) protein family. Whereas HIF-1b, the previously described aryl hydrocarbon receptor nuclear translocator, is quite stable under normoxic conditions, HIF-1a is extremely unstable and is quickly degraded by the ubiquitin-proteasome system (Salceda and Caro, 1997; Huang et al., 1998; Kallio et al., 1999) . The tumorsuppressor von Hippel-Lindau (VHL) protein interacts with hydroxylated HIF-1a at Pro564 of HIF-1a in the presence of oxygen, leading to the proteolysis of HIF-1a (Kamura et al., 2000; Tanimoto et al., 2000) . Specific HIF prolyl hydroxylases (PHDs) catalyse the hydroxylation of this proline residue in the oxygen-dependent degradation (ODD) domain of HIF-1a (Berra et al., 2003; Cioffi et al., 2003; Erez et al., 2003) . Three human PHDs, that is, PHD1, PHD2, and PHD3, are expressed ubiquitously, although each isoform differs in the relative amounts of transcripts expressed (Cioffi et al., 2003) . HIF-1a is acetylated at the Lys532 residue in the ODD domain by the acetyltransferase, arrest defective (ARD)1. Acetylation of HIF-1a can be coordinated with prolyl hydroxylation and ubiquitination, which lead to the proteasomal degradation of HIF-1a (Jeong et al., 2002) . Recently, several human and mouse ARD1 variants were identified and characterized. Among these, mouse ARD1 225 showed the strongest activity in degradation of HIF-1a (Kim et al., 2006) . Under hypoxic conditions, HIF-1a translocates into the nucleus, dimerizes with HIF-1b, and then recruits transcriptional co-activators, such as the cyclic-AMP-response-elementbinding protein (CBP)/p300, for further activation (Ema et al., 1999) . Under normoxic conditions, the cooperative binding of VHL and the factor inhibiting HIF-1 (FIH-1), which recruits histone deacetylases to HIF-1a, represses the transactivation function of HIF-1a (Mahon et al., 2001) . FIH-1 functions as an asparaginyl hydroxylase that modifies Asn803 of HIF-1a using an oxygen molecule, which results in the dissociation of HIF-1a and its co-activator p300 (Lando et al., 2002) .
Nur77, together with the neuron-derived orphan receptor-1 (Nor-1) and Nurr1, belongs to the NR4A subfamily of the steroid/thyroid-hormone receptor superfamily, which are transcriptional factors that positively or negatively regulate gene expression (Winoto, 1997; Hsu et al., 2004) . They are composed of an N-terminal transactivation domain, a DNA-binding domain and a C-terminal ligand-binding domain (Winoto, 1997; Hsu et al., 2004) . The NR4A subfamily members contain conserved, tightly packed, bulky hydrophobic residues that occupy the space usually associated with ligand binding, suggesting that they do not require a ligand for transactivation (Wang et al., 2003) . Important functions of NR4A proteins in both cellular proliferation and apoptosis have been described (Hazel et al., 1988; Williams and Lau, 1993; Li et al., 2000; Kolluri et al., 2003) . The NR4A subfamily has subsequently been implicated in biological and pathophysiological contexts such as immune development, immunological disorders, neuroendocrine regulation, liver regeneration and cancer (Scearce et al., 1993; Zhou et al., 1996; Zetterstrom et al., 1997; Li et al., 1998; Murphy et al., 2001) . Recently, NR4A subfamily members have emerged as potentially important factors in the complex network of proteins that regulate endothelial cell activation and vascular smooth muscle cell (VSMC) proliferation, their role has been implicated in vascular diseases such as atherosclerosis (Arkenbout et al., 2002; Gruber et al., 2003; Martinez-Gonzalez et al., 2003; Martinez-Gonzalez and Badimon, 2005; Rius et al., 2006) . In the previous study, we reported that Nur77 has a novel function that enhances the transcriptional activity of HIF-1a by stabilizing the protein (Yoo et al., 2004) .
6-Mercaptopurine (6-MP), a nucleic acid analog, regulates the transactivation of the Nur77 subfamily members through the AF-1 domain (Wansa et al., 2003) . 6-MP has been used for the treatment of inflammatory bowel disease, acute lymphoblastic leukemia of childhood, systemic lupus erythematosus, inflammatory myopathies and rheumatoid arthritis (Aarbakke et al., 1997) . It has also been used for the prevention of acute rejection in organ transplant patients (Murray et al., 1963; Aarbakke et al., 1997) . In the present investigation, we analysed the effects of 6-MP on the stabilization of HIF-1a and suggest a potential application of this drug in therapies for human HIF-1-associated vascular diseases.
Results

6-MP increases the transcriptional activity of HIF-1a via the induction of Nur77 subfamily genes
We previously reported that Nur77 enhances the transcriptional activity of HIF-1a, thereby increasing the expression of the vascular endothelial growth factor (VEGF), a downstream target gene of HIF-1 (Yoo et al., 2004) . Recently, 6-MP was identified as an activator of the NR4A subfamily members Wansa et al., 2003) ; therefore, we examined the possibility that 6-MP modulates hypoxic signaling through the activation of Nur77. Consistent with a previous report, the expression of Nur77, HIF-1a and VEGF proteins was induced under hypoxic conditions in HepG2 cells (Figure 1a ) (Yoo et al., 2004) . Similarly, treatment with 6-MP strongly induced the expression of Nur77 protein. The induction of Nur77 was accompanied by an increase in the protein level of HIF-1a and VEGF. The induction of Nur77 was observed as early as 30 min after treatment, and it continued for at least 24 h (Figure 1b ). Nurr1 and Nor-1, other members of the NR4A subfamily, were also induced by 6-MP treatment. We asked whether Nurr1 and Nor-1 possess the same property of Nur77 in the modulation of HIF-1 function. Similar to Nur77, the HIF-1a protein was induced upon expression of Nurr1 and Nor-1 in HeLa cells (Figure 1c ) (Yoo et al., 2004) . After transfection of a plasmid encoding a dominant-negative Nur77 mutant gene (DNNur77), which downregulates the function of the Nur77 family genes, the hypoxia-mediated as well as the 6-MPmediated induction of Nur77, Nurr1 and Nor-1 proteins was abolished (Figure 1d ) (Cheng et al., 1997) . In a similar manner, the expression of HIF-1a and VEGF was strongly suppressed (Figure 1d ). When the expression of Nur77 was repressed by transfection of small interfering RNA duplexes (si-RNA) targeting Nur77 (si-Nur77s), the induction of HIF-1a by 6-MP was eliminated (Figure 1e ). Although the sequences of si-Nur77s were unique to Nur77, the expression of Nurr1 and Nor-1 was also repressed, which may represent a transcriptional regulatory control of the induction of Nurr1 and Nor-1 by Nur77. These results indicate that the induction of HIF-1a and VEGF by 6-MP is mainly mediated by the Nur77 subfamily members.
Next, we carried out reporter gene analysis to examine the effects of 6-MP on the transcriptional activity of Nur77 and HIF-1a. The reporter construct encoding the Nur77-binding response element (NBRE) was activated in a dose-dependent manner by 6-MP treatment in HepG2 cells. The reporter construct containing the Nur77 promoter was also activated by 6-MP treatment, indicating that 6-MP induces Nur77 gene expression at the transcription level. A treatment with 100 mM 6-MP induced the reporter activities approximately twofold to compare with the treatment of phorbol 12-myristate 13-acetate (PMA) and ionomycin, well-known activators of Nur77 (Figure 2a) . A reporter construct containing either the hypoxia response element (HRE) or the VEGF promoter was activated in the presence of 6-MP, indicating that 6-MP induced transcriptionally active HIF-1 (Figure 2b ). It has been reported that thiopurine compounds such as 6-MP-riboside (6-MPR), 6-MP-deoxy-riboside (6-MPdR), 6-MP-monohydrate (6-MPmh) activate NR4A subfamily members Wansa et al., 2003) . When these compounds were tested for their ability to transactivate HIF-1 using the HRE-Luc reporter construct, they were almost as efficient as 6-MP (Figure 2c ).
6-MP increases the stability of HIF-1a protein
To examine the mechanism by which 6-MP induces the expression of Nur77 and HIF-1a at the protein level, we first evaluated their mRNA level using reverse transcriptase-polymerase chain reaction (RT-PCR). Consistent with the results of the reporter gene assay using the Nur77-promoter-Luc, Nur77 mRNA was significantly induced (Figure 3a) . The time course of Nur77 mRNA induction was similar to that of Nur77 protein.
Transcripts of Nurr1 and Nor-1 were also increased by 6-MP treatment (Figure 3a ). In contrast, the level of HIF-1a mRNA remained unchanged, whereas that of VEGF was significantly increased by 6-MP treatment (Figure 3a) . These results suggest that 6-MP increases the protein stability of HIF-1a but not the transcription of its gene. Therefore, we measured the stability of glutathione-S-transferase (GST)-fused HIF-1a chimera, GST-HIF-1a, in the presence of cycloheximide, which blocks de novo protein synthesis. Most GST-HIF-1a was degraded within 5 min under normoxia, but the integrity of HIF-1a was maintained under hypoxia or in the presence of 6-MP for up to 60 min (Figure 3b ). When the expression of HIF-1a protein was examined by fluorescence microscopy using green fluorescent protein (GFP)-fused HIF-1a, it was barely detectable in the absence of CoCl 2 . However, it accumulated in the nucleus in the presence of CoCl 2 as reported previously (Figure 3c ) (Kong et al., 2004; Yoo et al., 2004) . Similarly, fluorescence of the GFP-HIF-1a was enhanced and accumulated in the nucleus when cells were treated with 6-MP. Together, these results indicate that 6-MP increases the stability of HIF-1a protein.
To study the signaling pathway that is involved in the 6-MP-induced stabilization of HIF-1a protein, we used PD98059, Wortmannin and H89, which block the signaling pathway of extracellular signal-regulated kinases (ERKs), phosphatidylinositol-3 kinase and 
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protein kinase A, respectively. Western blot analysis showed that the 6-MP-induced HIF-1a protein was significantly diminished by 100 mM PD98059 but not by 30 nM Wortmannin or 1 mM H89, at which concentration is specific for inhibiting phosphatidylinositol-3 kinase or protein kinase A signaling pathway, respectively. (Chijiwa et al., 1990; Cuenda and Alessi, 2000) ( Figure 3d ). Although the involvement of mitogenactivated protein kinase (MAPK) pathway in maintaining the stability of HIF-1a has been contradictory in literature (Richard et al., 1999; Hur et al., 2001 ), we and others have shown that inhibition of p42/p44 ERKs by PD98059 diminished the stability of HIF-1a (Yoo et al., 2003 (Yoo et al., , 2004 Li et al., 2004; Zhang et al., 2005) . Consistent with the previous results, activation of p42/p44 ERKs as well as stability of HIF-1a was significantly induced under hypoxia and repressed by PD98059 (Figure 3d ) (Yoo et al., 2003 (Yoo et al., , 2004 Li et al., 2004; Zhang et al., 2005) . Similarly, 6-MP increased phosphorylated p42/p44 ERKs, whereas PD98059 decreased the phosphorylation of p42/p44 as well as the protein level of both HIF-1a and Nur77 ( Figure 3d ). These results suggest that the ERK pathway is primarily involved in the 6-MP-induced HIF-1a protein stability. . After 24 h of transfection, the cells were incubated in the media containing 1% FBS. The cells were treated with the indicated concentrations of 6-MP or for 24 h. Treatments with PMA (10 ng/ml) and ionomycin (0.5 mM) for 6 h, or 100 mM CoCl 2 for 24 h, were shown as positive controls. (c) HepG2 cells were transfected with the HRE-Luc (0.1 mg). After 24 h of transfection, the cells were incubated in the media containing 1% FBS. The cells were treated with 10, 50 or 100 mM each 6-MP, 6-MPR, 6-MPdR or 6-MPmh or 100 mM DFO for 24 h. At the end of treatment, cell lysates were obtained and luciferase activity was determined using an analytical luminescence luminometer. Luciferase activity was normalized for transfection efficiency using the corresponding b-gal activity. Data shown are the mean7s.d. of three or four independent determinations. *Po0.005, **Po0.001.
Potential molecular mechanisms by which 6-MP induces transcriptional activity of HIF-1a Previously, we showed that the binding of HIF-1a to mouse double minute (MDM)2 was significantly decreased in the presence of Nur77, which may indicate the mechanism of Nur77-induced HIF-1a stabilization (Yoo et al., 2004) . Therefore, we examined whether 6-MP influences the association of HIF-1a with either MDM2 or VHL, which subsequently drives the ubiquitinproteasomal degradation of HIF-1a. When cells were treated with MG132, the binding of HIF-1a to MDM2 or VHL was strong. However, these associations were abolished under hypoxia or in the presence of 6-MP (Figure 4 ). Consistent with our previous observation that Nur77 downregulates the expression of MDM2, the level of MDM2 protein was significantly decreased by 6-MP treatment (data not shown) (Yoo et al., 2004) . These results suggest that 6-MP decreases the expression of MDM2 as well as abolishes the proper association of HIF-1a with VHL, and consequently enhances the stability of HIF-1a.
Because acetylation is an important post-translational modification that regulates the stability of HIF-1a, we investigated whether acetylation of HIF-1a is involved in the 6-MP-induced stabilization of HIF-1a ( 6 cells/dish) were seeded in 100-cm 2 dishes and incubated overnight in the media containing 1% FBS. Then cells were treated with 50 mM 6-MP for the indicated time periods (lower panel). At the end of treatment, the expression of Nur77, VEGF, HIF-1a, Nurr1 and Nor-1 transcripts were analysed using RT-PCR. The expression of b-actin was monitored as control. (b) HeLa cells (4 Â 10 5 cells/well) were seeded in six-well culture plates and incubated overnight. The cells were transfected with 2 mg expression vector for GST-HIF-1a. Cells were treated with (m) or without (') hypoxia, or 50 mM 6-MP () for 24 h. At the end of incubation, the cells were treated with 10 mM cycloheximide (CHX) for the indicated time period. The expression of GST-HIF-1a and a-tubulin was analysed by WB analysis. The density of the GST-HIF-1a protein band was determined using an image analysis system. The values were normalized to that of a-tubulin and expressed as percent of the CHX-untreated control value. (c) 293 cells (1.5 Â 10 4 cells/chamber) that had been plated the previous day on four-chamber slide glass were transfected with 0.5 mg expression vector for GFP-HIF-1a. Transfected cells were treated with either 100 mM CoCl 2 or 50 mM 6-MP for 24 h. At the end of treatment, cells were fixed and visualized by fluorescence microscopy. 4,6-diaminidino-2-phenylindole was used to stain the nuclei. (d) HeLa cells (8 Â 10 5 cells/well) were seeded in six-well culture plates and incubated overnight. The cells were treated with or without 100 mM PD98059, 30 nM Wortmannin or 1 mM H89 for 1 h, and the treatment was continued with 50 mM 6-MP for 24 h (upper panel). The cells were treated with or without 100 mM PD98059 for 1 h, and the treatment was continued with hypoxia or 50 mM 6-MP for 24 h (lower panel). The expression of HIF-1a, Nur77, phosphorylated p42/p44 (p-p42/p44), p42/p44 and a-tubulin was analysed by WB analysis. One representative of at least three independent experiments with similar results is shown.
6-MP enhances transcriptional activity of HIF-1a Y-G Yoo et al treated with MG132, the level of acetylated HIF-1a increased significantly under normoxia, but no acetylated HIF-1a was detected under hypoxia or in the presence of 6-MP (Figure 5a ). To test the involvement of ARD1 in the action of 6-MP, HeLa cells were transfected with GST-HIF-1a (Figure 5b) . Expression of ARD1 strongly decreased the expression of GST-HIF1a at the protein level, whereas these levels were restored by treating the cells with either hypoxia or 6-MP (Figure 5b ). Because Lys532 of HIF-1a is the target site for ARD1 (Jeong et al., 2002) , we tested whether the stability of a mutant with a point mutation at this site, K532R, was affected by 6-MP treatment. The K532R mutant was stably expressed under normoxic conditions (Figure 5c ), which is consistent with a previous report (Jeong et al., 2002) . Although the protein level of the wild-type HIF-1a was largely varied in the presence of 6-MP and trichostatin A (TSA), the expression of K532R was not altered under these conditions. Thus, Lys532 may be an important aminoacid residue that regulates the 6-MP induced stability of HIF-1a protein. These results suggest that 6-MP affects the acetylation/deacetylation status of HIF-1a by modulating enzyme activities associated with this post-translational modification.
Nur77 increases both the stability and the transactivation function of HIF-1a protein (Yoo et al., 2004) . To test the effects of 6-MP on the transactivation function of HIF-1a, we used the GAL4-driven reporter system. 6-MP enhanced the GAL4-tk-Luc activity as strongly as CoCl 2 (Figure 6a ). Consistent with this result, the association between HIF-1a and CBP was increased in the presence of 6-MP. HIF-1a was strongly bound to FIH-1, which was shown to repress the transcriptional activity of HIF-1 (Mahon et al., 2001) , in the presence of MG132. However, the binding was not detected when cells were exposed to hypoxia or 6-MP (Figure 6b ). 5 cells/dish) were seeded in 60-cm 2 dishes and incubated overnight. Cells were treated with 10 mM MG132 for 1 h, hypoxia for 24 h or 50 mM 6-MP for 24 h, as indicated. Whole-cell lysates (500 mg) were IP with anti-pan-Ac antibody, and then probed using anti-HIF-1a antibody. (b) HeLa cells (8 Â 10 5 cells/dish) were seeded in 60-cm 2 dishes and incubated overnight. Cells were transfected with 4 mg expression vector for GST-HIF-1a with 3 mg expression vector for Myc-ARD1 or 3 mg empty vector (EV). After 1 h of transfection, cells were treated with hypoxia, or 50 mM 6-MP for 24 h. Whole-cell lysates (500 mg) were IP with anti-pan-Ac antibody, and then probed using anti-GST antibody. (c) HEK293 cells (1 Â 10 6 cells/well) were seeded into six-well culture plates and incubated overnight. Cells were transfected with the indicated combinations of 3 mg each expression vector for FLAG-HIF-1a (WT), or FLAG-K532R mutant (K532R). After 24 h of transfection, cells were incubated in the presence or absence of 300 ng/ml TSA for 3 h before being harvested. The expression of HIF-1a, GST-HIF-1a, Myc-ARD1, FLAG-HIF-1a and a-tubulin was analysed by WB analysis. One representative of at least three independent experiments with similar results is shown.
HIF-1α
α-tubulin Figure 4 The association between HIF-1a to VHL or MDM2 is decreased in the presence of 6-MP. HeLa cells (8 Â 10 5 cells) were seeded in 60-cm 2 dishes and incubated overnight. The cells were transfected with 3 mg each expression vector for Myc-VHL and MDM2 as indicated. After 1 h of transfection, cells were treated with 10 mM MG132 for 1 h, hypoxia for 24 h or 6-MP for 24 h. Whole-cell lysates (500 mg) were immunoprecipitated (IP) with anti-HIF-1a antibody, and then probed using anti-MDM2 or anti-Myc antibodies. The expression of HIF-1a, MDM2, Myc-VHL and atubulin was analysed by WB analysis. One representative of at least three independent experiments with similar results is shown.
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6-MP increases the capillary-tube formation of human umbilical vein endothelial cells
Finally, we tested whether 6-MP induces the stabilization of HIF-1a in human umbilical vein endothelial cells (HUVECs), because vessel endothelium is one of the tissues most sensitive to hypoxia. As shown in Figure 7a , the induction of HIF-1a protein was accompanied by the induction of Nur77 subfamily genes after treatment with 6-MP. VEGF protein was also induced by 6-MP, indicating that the transcriptional activity of HIF-1a was enhanced in HUVECs in the presence of 6-MP. Because capillary-tube formation is a key phenotype of the angiogenesis induced by VEGF, we tested whether 6-MP affected the capacity of HUVECs to form capillary tubes. HUVECs cultured on matrigel formed an extensive network under hypoxic conditions. When cells were treated with 10 mM 6-MP under normoxic conditions, capillary-tube formation increased to the level achieved under hypoxia. Capillary-tube formation was increased dose dependently after 6-MP treatment (Figure 7b ). These results demonstrate that 6-MP enhances the transcriptional activity of HIF-1a, thereby the expression of VEGF, which is a strong angiogenic factor that induces capillary-tube formation in vascular endothelial cells.
Discussion 6-MP and its long-lived prodrug, azathioprine, are among the oldest pharmacological immunosuppressive agents in use today. They have been used in the treatment of hematological malignancies, rheumatological diseases, solid organ transplantation and inflammatory bowel disease, and also for the prevention of acute rejection in organ transplant patients (Murray et al., 1963; Aarbakke et al., 1997) . 6-MP belongs to a class of nucleic acid analogs and is activated intracellularly in an anabolic transformation to a series of 6-thioguanine nucleotides that act as purine antagonists via their incorporation into DNA molecules (Aarbakke et al., 1997) . Also it has been shown that 6-MP decreases the de novo synthesis of adenosine and guanosine, which blocks the rapid replication of cells (Weigel et al., 1999) . These effects are considered to be the main mechanism of 6-MP action, which results in inhibiting the proliferation of immune cells such as B cells and T cells. Here, we report that 6-MP increases the transcriptional activity of HIF-1a and VEGF expression through activation of Nur77 subfamily members. This may provide new insight into the clinical applications of this drug in targeting various human vascular diseases. NR4A subfamily members, Nur77, Nurr1 and Nor-1, contain conserved, tightly packed, bulky hydrophobic residues that occupy the space usually associated with ligand binding, suggesting that they do not require ligand for transactivation (Hsu et al., 2004) . The fact that 6-MP induces the transcriptional activation of Nor-1 through AF-1 domain in N-terminus (Wansa et al., 2003) indicates that 6-MP is a unique activator that is different from a classical ligand. When we tested several 6-MP analogs for the activation of HIF-1, all the compounds exhibited similar effects to those of 6-MP (Figure 2c) . Recently, selected 1,1-bis(3-indolyl)-1-(p-anisyl)methanes were shown to induce ligand-dependent transcriptional activation of Nur77 through CBP. This class of Nur77 agonist induced cell death and inhibited tumor growth (Chintharlapalli et al., 2005) . It would be interesting to examine whether the biological function of Nur77 depends on which structural domain is activated, in such a way that N-terminus activation for vascular remodeling or LBD activation for cell death.
It is interesting to note that the expression of all three NR4A members was induced by 6-MP (Figure 1b) and 5 cells/ well) were seeded into 12-well culture plates, incubated overnight and then transfected with the Gal4-tk-Luc reporter (0.2 mg) and expression vector for Gal4-HIF-1a (50 ng). After 24 h of transfection, the cells were treated with either 100 mM CoCl 2 or the indicated concentrations of 6-MP for 24 h. At the end of treatment, cell lysates were obtained and analysed. Luciferase activity was normalized for transfection efficiency by corresponding b-gal activity. Data shown are the mean7s.d. of four independent determinations. ** Po0.001 (b) HeLa cells (2 Â 10 6 cells/dish) were seeded in 60-cm 2 dishes and incubated overnight. Cells were treated with 10 mM MG132 for 1 h, hypoxia for 24 h or 50 mM 6-MP for 24 h. Whole-cell lysates (500 mg) were IP with anti-HIF-1a, and then probed using anti-CBP, or anti-FIH-1 antibodies. The expression of HIF-1a, CBP, FIH-1 and a-tubulin was analysed by WB analysis. One representative of at least three independent experiments with similar results is shown.
6-MP enhances transcriptional activity of HIF-1a Y-G Yoo et al that the members have the same function in stabilizing HIF-1a (Figure 1c) . We have previously reported that Nterminus of Nur77 is sufficient to induce HIF-1a protein stability (Yoo et al., 2004) . Together, these results suggest that there may be 6-MP-regulated signaling cascades that are common to all the N-termini of Nur77 subfamily members. The signaling pathways may include kinase/ phosphatase activities, as phosphorylation occurs primarily at the N-terminus of Nur77 (Davis et al., 1993) . In our study, PD98059 almost completely blocked the 6-MP-induced expression of Nur77 and HIF-1a, indicating that 6-MP functions primarily through the activation of the ERK-signaling pathway (Figure 3d ). Consistent with our results, Thr142 residue of nerve growth factor (NGF)I-B was identified as a substrate for ERK2 in vivo and Ser105 was also shown to be phosphorylated by MAPK pathway when stimulated by NGF (Slagsvold et al., 2002) . Activation of MAPK signaling pathway by 6-MP seems to be unique for the Nur77-induced stabilization of HIF-1a, because 6-MP suppresses mitogen-induced extracellular kinase (MEK) phosphorylation when it leads to the mitochondrial apoptotic pathway in primary human CD4 þ T lymphocytes (Tiede et al., 2003) . MEKK1 also suppresses the mitogenic effect of Nur77 that is induced by the epidermal growth factor and serum, by inhibiting its DNA binding and transactivation function in lung cancer cell lines (Kolluri et al., 2003) . The different usage of a single signaling pathway may be related to the cell-type-and stimulus-specific biological function of Nur77 subfamily members.
ARD1-induced acetylation is one of the important epigenetic modifications of HIF-1a that regulate the stability of HIF-1a protein (Jeong et al., 2002) . However, the role of ARD1 in the regulation of HIF1a has been contradictory in that both the overexpression and silencing of ARD1 has no impact on the stability of HIF-1 or the mRNA levels of downstream target genes of HIF-1 (Bilton et al., 2005; Fisher et al., 2005) . Recently, we showed that mARD1 225 -induced acetylation was repressed under hypoxia or in the presence of metastasis-associated protein 1 (Yoo et al., 2006) , which strongly supports the role of ARD1 in the regulation of HIF-1a stability. In the present investigation, the mARD1 225 -induced decreases of GST-HIF-1a was restored in the presence of 6-MP, indicating that deacetylation of HIF-1a is one of the major targets of 6-MP/Nur77 function ( Figure 5 ). In addition, 6-MP abolishes the binding of HIF-1a to MDM2 and VHL (Figure 4 ). This result indicates that prolyl hydroxylation status of HIF-1a is also important in the 6-MPinduced stabilization of HIF-1a. Together, our results suggest that 6-MP effectively increases the stabilization of HIF-1a via multiple steps, although it is not clearly understood whether these events are biochemically interconnected or not.
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Vascular remodeling represents the changes in growth of both vascular endothelial cells and VSMCs that are critical in the pathological processes of many human diseases, including atherosclerosis. Recently, NR4A subfamily genes have been suggested as the early genes controlling vascular remodeling (Martinez-Gonzalez et al., 2003) . Here, our observation that the function of Nur77 is linked to the stability of HIF-1a may provide a critical clue to the role of Nur77 subfamily members in vascular remodeling. Although Nur77, Nurr1 and Nor-1 are expressed in human atherosclerotic lesions, experimental results have so far been inconsistent regarding the function of these proteins. In a model of carotid artery ligation in Nur77 transgenic mice, atherosclerotic lesion formation decreased to the level observed in wild-type mice, which supports a protective function for Nur77 in atherogenesis (Arkenbout et al., 2002) . However, antisense oligodeoxynucleotides directed against Nor-1 efficiently prevented cell-cycle progression in serumactivated or low-density lipoprotein-activated VSMCs, indicating that Nor-1 enhances the proliferation of VSMCs (Martinez-Gonzalez et al., 2003) . The role of the Nur77 family in the proliferation of endothelial cells is also contradictory. Adenoviral overexpression of Nur77 in cultured endothelial cells resulted in cell-cycle arrest (Arkenbout et al., 2003) . In contrast, Zeng et al. (2006) showed that TR3/Nur77 is necessary and sufficient for VEGF-A-induced proliferation and survival of cultured HUVECs and for angiogenesis in vivo. Antisense oligonucleotides directed against Nor-1-inhibited VEGFinduced endothelial cell growth (Rius et al., 2006) . Here, we showed that expression of all three members of the Nur77 subfamily was increased in HUVECs after 6-MP treatment ( Figure 7 ) and that the members have the same function in stabilizing HIF-1a (Figure 1c) . Further, the fact that capillary-tube formation capacity of HUVECs is enhanced by 6-MP, supports the role of the Nur77 family in the proliferation of endothelial cells (Figure 8 ). Although the bases of the reported contradictions are not yet clearly understood, there is no doubt that Nur77 family members are involved in vascular remodeling. Therefore, further investigations, including in vivo studies of 6-MP on the atherosclerotic lesion formation and the identification of downstream target genes of Nur77/ 6-MP in vascular remodeling, are essential in understanding the pathophysiology of atherosclerosis. These investigations may also provide the basis for pharmaceutical and therapeutic interventions targeting hypoxiaassociated human vascular diseases.
Materials and methods
Cell culture and hypoxic treatment Human hepatocellular carcinoma cell line, HepG2 (ATCC HB 8065), human cervical carcinoma cell line, HeLa (ATCC CCL-2), and human embryonal kidney cell line, HEK293 (ATCC CRL-1573), were obtained from American type culture collection. Cells were maintained in Dulbecco's modified eagle's medium containing 10% fetal bovine serum (FBS) or calf serum. HUVECs were isolated from freshly obtained human umbilical cords as described (Gimbrone et al., 1974) and were maintained in M199 medium (Join Bio Innovation, Seoul, Korea) containing 20% FBS, 20 mg/ml endothelial cell growth supplement (Sigma, St Louis, MO, USA), 5 U/ml heparin, and 50 mg/ml of penicillin and streptomycin (Invitrogen, Carlsbad, CA, USA). HUVECs were used between passages three and 10. Cells were maintained at 371C in an atmosphere of humidified incubator with 5% CO 2 and 95% air. Cells were exposed to hypoxia, 0.1% O 2 , by incubating cells at 371C in 5% CO 2 /10% H 2 /85% N 2 anaerobic incubator (Forma Scientific). Hypoxia was also induced chemically by treating cells with 100 mM CoCl 2 (Sigma), or 100 mM desferrioxamine (DFO) (Calbiochem, San Diego, CA, USA). (Yoo et al., 2004) . For coimmunoprecipitation assays, HIF-1a protein was precipitated using 1 mg anti-HIF-1a antibody, and probed with anti-MDM2, anti-Myc, anti-CBP or anti-FIH-1 antibodies. To detect the acetylated HIF-1a, 500 mg whole-cell lysates were incubated with 1 mg anti-pan-Ac antibody (Santa Cruz Biotechnology), precipitated by adding 40 ml protein-A or G agarose slurry, and then probed with anti-HIF-1a or anti-GST antibodies (Yoo et al., 2006) . Immunofluorescence study was carried out basically as described previously using GFP-HIF1a (Yoo et al., 2003) .
Plasmids and transient transfection
The NBRE-Luc, Nur77 promoter (À454 to 57)-Luc, HRE-tkLuc, VEGF promoter (À2068 to þ 50)-Luc and Gal4-tk-Luc reporter constructs have been described previously (Yoo et al., 2003 (Yoo et al., , 2004 . The eukaryotic expression vectors for pCMXNurr1 (Nurr1), pCMX-Nor-1 (Nor-1), the DN Nur77, p3XFLAGt7.1-Nur77 Hga (DN-Nur77), pEGFP-C3-HIF-1a (GFP-HIF-1a), pEBG-HIF-1a, (GST-HIF-1a), pCMV-Myc-VHL (Myc-VHL), pCMV-MDM2 (MDM2), pCMV-Tag3C-Myc-mARD1 225 (Myc-ARD1), the FLAG-tagged wild-type HIF-1a, p3XFLAGt7.1-HIF-1a (WT), and the K532R mutant, p3XFLAGt7.1-HIF-1a K532R (K532R) and GAL4-HIF-1a were described previously (Yoo et al., 2003 (Yoo et al., , 2004 (Yoo et al., , 2006 . For transient expression of protein, HeLa cells were seeded in either six-well culture plate or 60-cm 2 dishes and incubated overnight. The cells were transfected with 3-9 mg expression vectors using Polyfect (Qiagen, Chatworth, CA, USA) or WelFect-EXtPLUS (WelGENE Inc., Korea) as described previously (Yoo et al., 2003 (Yoo et al., , 2004 (Yoo et al., , 2006 . For reporter gene analysis, HepG2 cells were seeded in 12-well culture plates and transfected with reporter plasmid (0.1-0.3 mg), and b-galactosidase (b-gal) expression vector (0.2 mg) using LipofectaminePlus (Invitrogen) as described previously. At the end of treatment, luciferase activity was determined using an Analytical luminescence luminometer. Luciferase activity was normalized for transfection efficiency using the corresponding b-gal activity.
Transfection of si-RNA duplexes
The si-RNA targeting Nur77 (si-Nur77 no. 1, 5 0 -CAGUCCA GCCAUGCUCCUTT-3 0 , 5 0 -AGGAGCAUGGCU GGACU GTT-3 0 (Maddika et al., 2005) ; si-Nur77 no.2, 5 0 -GAAG GAAGUUGUCCGAACATT-3 0 , 5 0 -UGUUCGGACAACU UCCUUCTT-3 0 ), and the nonspecific control si-RNA (si-GL3, 5 0 -CUUACGCUGAGUACUUCGATT-3 0 , 5 0 -UCGAAGUA CUCAGCGUAAGTT-3 0 ) were synthesized and purified by Shamchully Pharm Co. (Korea). The transfection of si-RNAs was performed twice at 24 h intervals with Oligofectamine reagent (Invitrogen) as described previously (Yoo et al., 2006) .
Reverse transcriptase-polymerase chain reaction Total RNA was prepared using an RNeasy kit (Qiagen). PCR reaction was performed as described previously with specific primers for HIF-1a (forward: 5 0 -CCCCAGATTCAGGAT AGACA-3 0 , reverse: 5 0 -CCATCATGTTCCATTTTTCGC-3 0 ), VEGF (forward: 5 0 -CTGCTGTCTTGGGTGCATTGG-3 0 , reverse: 5 0 -CACCGCCTCGGCTTGTCACAT-3 0 ), Nur77 (forward: 5 0 -CGACCCCCTGACCCCTGAGTT-3 0 , reverse: 5 0 -GCCCT CAAGGTGTTGGAGAAGT-3 0 ) and b-actin (forward, 5 0 -CG TGGGCCGCCCTAGGCACCA-3 0 ; reverse, 5 0 -TTGGCTTA GGGTTCAGGGGGG-3 0 ). Genes were analysed under the same condition used to exponentially amplify the PCR products.
Capillary tube formation assay
The 96-well plates were coated with Matrigel (BD Biosciences) by incubating at 371C for 1 h. HUVECs were suspended in media supplemented with 10% FBS and endothelial cell growth supplement, plated in triplicate at a density of 2 Â 10 4 cells/well. The cells were treated with various concentrations of 6-MP for 24 h. As a positive control, the cells were incubated under hypoxic condition, 0.1% O 2 , for 24 h. The morphological changes in the cells and the closed networks of vessel-like tubes were observed under an inverted microscope and photographed using a JVC digital camera (TKC1380U; Victor Company of Japan). Complete networks were counted.
Statistical analysis
Experimental values were expressed as mean7s.d. The significance of differences was determined by Student's t-test and expressed as a probability value. Mean differences were considered to be significant when Po0.05.
